State of Wyoming’s MaxCyte MXCT Stock Holding History

State of Wyoming’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-27,406	Closed	-$42.5K	–	1953
2025 Q4	$42.5K	Buy	27,406 +4,894	+22%	+$7.82K	﹤0.01%	1585
2025 Q3	$35.6K	Buy	22,512 +4,956	+28%	+$8.61K	﹤0.01%	1640
2025 Q2	$38.3K	Buy	+17,556	New	+$42.5K	﹤0.01%	1624
2024 Q4	–	Sell	-12,413	Closed	-$48.3K	–	1770
2024 Q3	$48.3K	Buy	+12,413	New	+$52.3K	0.01%	1467
2024 Q2	–	Sell	-8,991	Closed	-$37.7K	–	1798
2024 Q1	$37.7K	Buy	+8,991	New	+$42.2K	0.01%	1435
2022 Q3	–	Sell	-4,071	Closed	-$19K	–	1787
2022 Q2	$19K	Buy	+4,071	New	+$20.1K	0.01%	1443

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

State of Wyoming's MXCT Position: Q1 2026 in Review

State of Wyoming sold out of MaxCyte (MXCT) in Q1 2026, closing a stake of 27,406 shares — an estimated $42.5K sold.

State of Wyoming first reported a position in MXCT in Q2 2022 and held it in 6 quarters. The position peaked at $48.3K in Q3 2024. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

State of Wyoming reported no remaining MaxCyte position as of Q1 2026 after selling out during the quarter.
State of Wyoming sold 27,406 MaxCyte shares in Q1 2026, an estimated $42.5K.
State of Wyoming first reported a position in MaxCyte in Q2 2022 and held it in 6 quarters.
State of Wyoming's MaxCyte position peaked at $48.3K in Q3 2024.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.